Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for Type 2 Diabetes
60 locations incl. Chandler
Sponsor: Sparrow Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07296484·Phase 2·Recruiting·Listed Dec 2025
University of North Carolina at Chapel Hill
Clinical research site in Chapel Hill, North Carolina · 101 MANNING DR, CHAPEL HILL, NC 27514-4220 · (919) 966-4676
Part of UNC Chapel Hill
As of July 2026, 178 paid clinical trials are recruiting at University of North Carolina at Chapel Hill in Chapel Hill, North Carolina. Active studies at this site cover conditions such as ARDS, ARDS (Acute Respiratory Distress Syndrome) and Acute Respiratory Distress Syndrome. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at University of North Carolina at Chapel Hill (178)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
94 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
91 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for Colorectal Neoplasms
79 locations incl. Gilbert
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06662786·Phase 3·Recruiting·Listed Oct 2024
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for Diabetes Mellitus, Type 2
123 locations incl. Chandler
Sponsor: Cleerly, Inc.
Sex: All·Age: 55+·Accepts healthy volunteers
Code: NCT06112418·Recruiting·Listed Nov 2023
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
37 locations incl. Birmingham
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06973187·Phase 3·Recruiting·Listed May 2025
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for Solid Tumors
43 locations incl. Tucson
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
for Cachexia
81 locations incl. Birmingham
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06989437·Phase 2, Phase 3·Recruiting·Listed May 2025
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for Chronic Lymphocytic Leukemia
35 locations incl. Laguna Hills
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06943872·Phase 3·Recruiting·Listed Apr 2025
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for Pancreatic Neuroendocrine Tumor (pNET)
40 locations incl. Birmingham
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06943755·Phase 2, Phase 3·Recruiting·Listed Apr 2025
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for Advanced Melanoma
44 locations incl. Gilbert
Sponsor: Replimune, Inc.
Sex: All·Age: 12+
Code: NCT06264180·Phase 3·Recruiting·Listed Feb 2024
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
37 locations incl. Birmingham
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT06901531·Phase 3·Recruiting·Listed Mar 2025
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
for Diabetes Mellitus, Type 1
57 locations incl. Scottsdale
Sponsor: vTv Therapeutics
Sex: All·Age: 18+
Code: NCT06334133·Phase 3·Recruiting·Listed Mar 2024
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
for Eosinophilic Esophagitis (EoE)
29 locations incl. Phoenix
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 1+
Code: NCT06693531·Recruiting·Listed Nov 2024
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for Ovarian Cancer
32 locations incl. Burbank
Sponsor: Daiichi Sankyo
Sex: Female·Age: 18+
Code: NCT06819007·Phase 3·Recruiting·Listed Feb 2025
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
for Heart Failure
57 locations incl. Phoenix
Sponsor: Abbott Medical Devices
Sex: All·Age: 18+
Code: NCT06526195·Recruiting·Listed Jul 2024
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for Urothelial Carcinoma
144 locations incl. Gilbert
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04879329·Phase 2·Recruiting·Listed May 2021
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for Type 2 Diabetes
41 locations incl. Tucson
Sponsor: Eli Lilly and Company
Sex: All·Age: 10 - 17
Code: NCT06739122·Phase 3·Recruiting·Listed Dec 2024
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
for Idiopathic Inflammatory Myopathy
31 locations incl. Orange
Sponsor: Cabaletta Bio
Sex: All·Age: 6 - 75
Code: NCT06154252·Phase 2, Phase 3·Recruiting·Listed Dec 2023
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for Melanoma, Cutaneous Malignant
37 locations incl. Phoenix
Sponsor: Immatics US, Inc.
Sex: All·Age: 18+
Code: NCT06743126·Phase 3·Recruiting·Listed Dec 2024
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
for Carcinoma, Squamous Cell
22 locations incl. Birmingham
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All·Age: 60+
Code: NCT04892173·Phase 3·Recruiting·Listed May 2021
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
66 locations incl. Birmingham
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for Adjustment Disorder
30 locations incl. Birmingham
Sponsor: Reunion Neuroscience Inc
Sex: All·Age: 18 - 80
Code: NCT07002034·Phase 2·Recruiting·Listed Jun 2025
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for Autosomal Dominant Polycystic Kidney Disease
35 locations incl. Garden Grove
Sponsor: Calico Life Sciences LLC
Sex: All·Age: 18 - 55
Code: NCT06902558·Phase 2·Recruiting·Listed Mar 2025
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for Graft-versus-host Disease (GVHD)
30 locations incl. Palo Alto
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06615050·Phase 3·Recruiting·Listed Sep 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
for Acute Respiratory Distress Syndrome (ARDS)
39 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06703073·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for Acute Respiratory Distress Syndrome (ARDS)
39 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701656·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for Acute Respiratory Distress Syndrome (ARDS)
39 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701669·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
for Acute Respiratory Distress Syndrome (ARDS)
39 locations incl. Birmingham
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701682·Phase 2·Recruiting·Listed Nov 2024
Global Paradise System US Post Approval Study
for Hypertension
39 locations incl. Sacramento
Sponsor: ReCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT06297291·Recruiting·Listed Mar 2024
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
for Leukemia, Myeloid, Acute
30 locations incl. Newport Beach
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 12+
Code: NCT04988555·Phase 1, Phase 2·Recruiting·Listed Aug 2021
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for cGVHD
31 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05919511·Recruiting·Listed Jun 2023
Registry for Stage 2 Type 1 Diabetes
for Type 1 Diabetes
37 locations incl. Los Angeles
Sponsor: Sanofi
Sex: All·Age: All ages
Code: NCT06481904·Recruiting·Listed Jul 2024
Zenith® Fenestrated+ Clinical Study
for Aortic Aneurysm, Abdominal
30 locations incl. Birmingham
Sponsor: Cook Research Incorporated
Sex: All·Age: 18+
Code: NCT04875429·Recruiting·Listed May 2021
Shield Post-Approval Study Protocol
for Colo-rectal Cancer
45 locations incl. Chandler
Sponsor: Guardant Health, Inc.
Sex: All·Age: 45 - 81·Accepts healthy volunteers
Code: NCT06880055·Recruiting·Listed Mar 2025
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
for AAA - Abdominal Aortic Aneurysm
56 locations incl. Little Rock
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06218875·Recruiting·Listed Jan 2024
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
for Diabetic Foot Ulcer
26 locations incl. Mesa
Sponsor: Piomic Medical
Sex: All·Age: 22 - 90
Code: NCT05758545·Recruiting·Listed Mar 2023
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for Hormone Receptor Positive HER-2 Negative Breast Cancer
34 locations incl. Birmingham
Sponsor: Puma Biotechnology, Inc.
Sex: All·Age: 18+
Code: NCT06369285·Phase 2·Recruiting·Listed Apr 2024
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for Myeloproliferative Neoplasms
22 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07441694·Phase 1·Recruiting·Listed Mar 2026
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for GIST - Gastrointestinal Stromal Tumor
16 locations incl. Los Angeles
Sponsor: Kumquat Biosciences Inc.
Sex: All·Age: 18+
Code: NCT07406633·Phase 2·Recruiting·Listed Feb 2026
Showing the 40 most relevant of 178 recruiting trials at this site. Browse all with filters →
More research sites in Chapel Hill
- University of North Carolina (98 trials)
- UNC Lineberger Comprehensive Cancer Center (87 trials)
- The University of North Carolina at Chapel Hill (18 trials)
- UNC Chapel Hill (17 trials)
- University of North Carolina Chapel Hill (13 trials)
- Lineberger Comprehensive Cancer Center (12 trials)
- University of North Carolina Medical Center (10 trials)
- University of North Carolina - Chapel Hill (9 trials)
- University of North Carolina, Chapel Hill (9 trials)
- UNC Hospitals, The University of North Carolina at Chapel Hill (9 trials)
Explore more
Paid clinical trials in Chapel Hill, NC · North Carolina clinical trials